Bandari et al. expanded this concept by designing a bivalent vector incorporating both GRPR/PSMA-targeting motifs, demonstrating effective tumor uptake but also liver and gastrointestinal accumulation, highlighting the need for further refinement [170]. The gene discussed is FOLH1; the disease is neoplasm.